Our Story – A founder’s Perspective
“She was a good person but still cancer won”
I believe in virtues, I believe in fairness. But nothing was fair in terminal illness.
The unfair thing is the acceptance that there isn’t treatment and the worst part is telling patients that we don’t have resources to find a treatment.
This statement has hit me hard and kept me awake at nights for answers. I have always felt if there were more medicinal chemists, more pharmaceutical scientists, and more people working on drug discovery, it could have yielded more drugs. In a very normal conversation with my co-founder (then just a friend who liked to have curious conversations), after a statistical discourse, we started ideating about regression models to predict properties of compounds. As he had interesting work experience in deep technology, we started to ideate an imaginary workflow and thus kick-started our journey into using AI/ML to support drug discovery pipelines.
Thus, the dream of “more medicinal chemists, more pharmaceutical scientists, and more people working on drug discovery” was fulfilled not by humans but by computers.
